Doceree Honored 25 Leaders in AI Healthcare
The awards recognized executives from pharmaceutical and medical technology firms.
Updated on Sept. 24, 2026 in Healthcare
Live Poll
Do you trust that increased AI use in healthcare will improve patient outcomes?
Doceree hosted the AI Health 25 ceremony at One World Observatory in New York City to recognize professionals driving artificial intelligence adoption. The event highlighted 25 leaders from sectors including pharmaceuticals and medical technology.
Why it matters
The recognition underscores the industry shift toward integrating AI into the development, marketing, and delivery of medicine. Honorees represent firms actively utilizing machine learning to influence medical operations and commercial strategy.
The AI Health 25 awards recognized 25 individuals across the marketing, pharmaceutical, and medical technology sectors. The event was held on the 102nd floor of the One World Observatory in New York City.
The players
Doceree
A digital advertising platform focused on the pharmaceutical and healthcare provider sectors.
Genentech
A biotechnology company that discovers, develops, and manufactures medicines for serious medical conditions.
Johnson & Johnson
A multinational corporation that develops medical devices, pharmaceuticals, and consumer health goods.
Eli Lilly
A global pharmaceutical firm focused on the discovery and development of human therapeutics.
The details
The editorial team at Doceree selected the honorees to represent the breadth of the healthcare industry, focusing on those implementing AI to transform operational workflows. Attendees participated in cocktail sessions and presentations at the ceremony, which served as a platform for highlighting digital innovation in medicine. The list includes high-level executives from companies such as Genentech, Johnson & Johnson, and Eli Lilly.
Timeline
September 23, 2026: The AI Health 25 awards evening took place.
Market Landscape
This event reflects the broader industry trend of accelerating AI adoption across medical R&D and commercial marketing operations. It aligns with the shift seen at major pharmaceutical players as they institutionalize machine learning tools to optimize their market presence.
Business owners should note which firms and executives are successfully deploying AI to gain a market advantage. Monitoring these industry leaders can help smaller operators identify scalable technological trends to integrate into their own commercial practices.
The takeaway
The AI Health 25 list signals which companies are currently prioritizing digital transformation in their medical delivery and marketing models. Operators should track these firms to understand the benchmarks for successful AI implementation in the healthcare sector.
Further reading
For broader analysis on medical industry innovation, see our Healthcare section.
Source note: This article includes information reported by Adweek.
Live Poll
Do you trust that increased AI use in healthcare will improve patient outcomes?
